Dob pri Domzalah, Slovenia

Maja Capuder



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maja Capuder: Innovator in Biotechnology

Introduction

Maja Capuder is a prominent inventor based in Dob pri Domzalah, Slovenia. She has made significant contributions to the field of biotechnology, particularly through her innovative work on the mt-pfkA gene. Her research focuses on the development of a modified protein that has potential applications in various biotechnological processes.

Latest Patents

Maja Capuder holds a patent for her invention related to the mutated truncated mt-pfkA gene. This gene encodes a shorter fragment of 6-phosphofructo-1-kinase (PFK1), which does not require phosphorylation for activation. Notably, this fragment is not significantly inhibited by citric acid, its salts, or ATP molecules. The active 49-52 kDa fragment retains the positive regulatory properties of the native protein and is activated in the presence of specific activators. This invention has promising implications for the fabrication of primary and secondary metabolites in biotechnological processes.

Career Highlights

Maja Capuder is affiliated with the Kemijski Institut, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing challenges in biotechnology. With a focus on enhancing the functionality of metabolic processes, she is paving the way for advancements in the field.

Collaborations

Maja collaborates with notable colleagues, including Matic Legisa and Mojca Bencina. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Maja Capuder is a trailblazer in the field of biotechnology, with her innovative work on the mt-pfkA gene showcasing her commitment to advancing scientific knowledge. Her contributions have the potential to impact various biotechnological applications significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…